A Study of Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer
NCT: NCT07575854 · NOT_YET_RECRUITING
広告
NCT識別子NCT07575854
ステータスNOT_YET_RECRUITING
開始日2026-10-01
完了2029-04-01
SponsorCentre Georges Francois Leclerc (OTHER)
First posted
Last updated
概要
This is a prospective, interventional, open-label, single-arm, multicenter pilot study evaluating the safety, tolerability and maximum tolerated dose (MTD) of splenic Selective Internal Radiation Therapy (SIRT) using TheraSphere in adult patietns with gastrointestinal cancer and chemotherapy-induced thrombocytopenia with splenomegaly
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。